ClinicalThought

Share

Program Content

Activities

  • FAQs on ICIs in NSCLC
    Expert Answers to FAQs on Immune Checkpoint Inhibitors for NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 26, 2022

    Expires: August 25, 2023

Provided by

ProCE Banner

Supporters

Lilly

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme